POLYPHARMACY AND THERAPEUTIC ADHERENCE IN PRIMARY HEALTH CARE: SCOPING REVIEW
DOI:
https://doi.org/10.56238/revgeov17n1-178Keywords:
Polypharmacy, Medication Adherence, Primary Health Care, Quality of Life, Young AdultAbstract
Considering the growing prevalence of polypharmacy in Primary Health Care (PHC), particularly among adults with chronic conditions, and its impact on therapeutic adherence, it is essential to understand the factors that interfere with this process. This study aims to map and critically discuss the scientific evidence on polypharmacy-related factors that influence therapeutic adherence and their implications for quality of life among adults receiving care in PHC. To this end, a scoping review was conducted in accordance with the Joanna Briggs Institute recommendations and the PRISMA-ScR checklist, with searches performed in six national and international databases up to June 2025. Studies published in Portuguese, English, or Spanish that addressed polypharmacy in the PHC context were included. The findings indicate that therapeutic adherence is shaped by individual, social, organizational, and therapy-related determinants, particularly regimen complexity, forgetfulness, low social support, failures in patient–provider communication, and structural limitations of health services. Multidisciplinary interventions, pharmacotherapeutic follow-up, and the use of clinical decision support technologies demonstrated potential to improve adherence; however, results were heterogeneous and strongly dependent on the care context. These findings suggest that promoting therapeutic adherence among patients with polypharmacy in PHC requires integrated, continuous, and patient-centered approaches capable of strengthening the rational use of medicines, the safety of care, and quality of life within the Unified Health System.
Downloads
References
ARRUDA, A. O.; DA SILVA, L. R.; MALHEIRO, L. H. The importance of the pharmacist in the pharmacotherapeutic follow-up in polymedicated elderly patients. ID Online Revista de Psicologia, v. 15, n. 58, p. 177-189, 2021. DOI: https://doi.org/10.14295/idonline.v15i58.3314
BALAJI, P. et al. Intelligent medication management system: enhancing patient-centric care with machine learning and IoT integration. In: 4th Asian Conference of Innovation in Technology, 2024, Pune, Índia. Proceedings. Piscataway: IEEE, 2024. p. 1-6. DOI: https://doi.org/10.1109/ASIANCON62057.2024.10837719
BEZERRA, Y. M. et al. Polypharmacy simulation and pharmacotherapy perceptions among students from a university in Ceará: a pilot study. Revista Brasileira de Educação Médica, v. 45, n. 3, p. 1-7, 2021. DOI: https://doi.org/10.1590/1981-5271v45.3-20210026.ING
BRASIL. Ministério da Saúde. Portaria nº 2.436, de 21 de setembro de 2017. Aprova a Política Nacional de Atenção Básica, estabelecendo a revisão de diretrizes para a organização da Atenção Básica, no âmbito do Sistema Único de Saúde (SUS). Brasília, DF: Ministério da Saúde, 2017. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html. Acesso em: 27 jan. 2026.
CANO-POLVILLO, M. J. et al. Adherence to treatment in polymedicated patients using Monitored Dosage Systems (MDS) and their impact on health. Farmacéuticos Comunitarios, v. 16, n. 1, p. 61-64, 2024. DOI: https://doi.org/10.33620/FC.2173-9218.(2024).07
CUNICO, C.; LEITE, S. N. Rare diseases: proposition of a list based on the Brazilian Health System. Expert Opinion of Orphan Drugs, v. 10, n. 1, p. 28-33, 2022. DOI: https://doi.org/10.1080/21678707.2022.2134008
CUTLER, R. L. et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open, v. 8, p. 1-13, 2018. DOI: https://doi.org/10.1136/bmjopen-2017-016982
DA SILVA, T. B.; ALVES-ZARPELON, S. P.; LAUREANO, J. V. CONCILIAÇÃO MEDICAMENTOSA EM UMA UNIDADE DE INTERNAÇÃO DE HOSPITAL PÚBLICO DO SUL DO BRASIL. Infarma - Ciências Farmacêuticas, v. 33, n. 2, p. 158-166, 2021. DOI: https://doi.org/10.14450/2318-9312.v33.e2.a2021.pp158-166
DE OLIVEIRA, A. M. et al. Contribution of pharmaceutical care to person-centered health care and the safety of pharmacotherapy for hospitalized older individuals in Brazil. Current Drug Safety, v. 18, n. 2, p. 253-263, 2023. DOI: https://doi.org/10.2174/1574886317666220614140433
DE SOUZA, L. C. P. et al. GESTÃO DO CUIDADO PARA PESSOAS COM DOENÇAS CRÔNICA. Estudos Avançados Sobre Saúde E Natureza, v. 2, p. 31-39, 2024. DOI: https://doi.org/10.51249/easn02.2024.1852
DWAJANI, S. et al. Importance of medication adherence and factors affecting it. IP International Journal of Comprehensive and Advanced Pharmacology, v. 3, n. 2, p. 69-77, 2018. DOI: https://doi.org/10.18231/2456-9542.2018.0018
FARIA, F. L. et al. Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-10, 2022. DOI: https://doi.org/10.1590/s2175-97902022e20400
GIACOMIN, R. S.; LIMA, N. S.; PINTO, E. V. Otimização da terapia medicamentosa em idosos polimedicados: um estudo sobre interações medicamentosas e a relevância das ferramentas informativas na atenção farmacêutica. Revista Ibero-Americana de Humanidades, Ciência e Educação – REASE, v. 10, n. 11, p. 2671-2696, 2024. DOI: https://doi.org/10.51891/rease.v10i11.16730
GOMES, D. et al. Daily medication management and adherence in the polymedicated elderly: a cross-sectional study in Portugal. International Journal of Environmental Research and Public Health, v. 17, n. 1, p. 1-13, 2019. DOI: https://doi.org/10.3390/ijerph17010200
HANLON, J. T. et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of Medicine, v. 100, n. 4, p. 428-437, 1996. DOI: https://doi.org/10.1016/s0002-9343(97)89519-8
HOVAL, T.; NEVASE, S. Assessment of patient medication adherence using digital health technologies: a research. Ijraset Journal For Research in Applied Science and Engineering Technology, v. 12, n. 4, p. 2311-2315, 2024. DOI: https://doi.org/10.22214/ijraset.2024.60289
JANDU, J. S. et al. Strategies to reduce polypharmacy in older adults. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK574550/. Acesso em: 27 jan. 2026.
JOANNA BRIGGS INSTITUTE (JBI). Manual for Evidence Synthesis.Appendix 11.2 PRISMA SCR extension Fillable checklist. JBI global wiki, 2021. Disponível em: https://jbi-global-wiki.refined.site/space/MANUAL/4688844/Appendix+11.2+PRISMA+ScR+Extension+Fillable+Checklist. Acesso em: 27 jan. 2026.
KIM, S. J. et al. Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: a nationwide study. PLoS One. v. 16, n. 2, p. 1-13, 2021. DOI: https://doi.org/10.1371/journal.pone.0244718
KLEIBERT, K. R. U. et al. Polymedication in sodium warfarin users of the Public Health System and associated variables. Revista Ciências em Saúde, v. 10, n. 2, p. 28-35, 2020. DOI: https://doi.org/10.21876/rcshci.v10i2.900
LIERMANN, A. C. A. S. et al. Desenvolvimento e validação de software para caracterizar interação medicamentosa em fármacos utilizados no Sistema Único de Saúde. 2021. Trabalho de Conclusão de Curso (Graduação em Medicina) – Universidade Positivo, Curitiba, 2021. Disponível em: https://repositorio.cruzeirodosul.edu.br/handle/123456789/3809. Acesso em: 27 jan. 2026.
LOZANO-HERNÁNDEZ, C. M. et al. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care: MULTIPAP Study. PLoS One, v. 15, n. 6, p. 1-15, 2020. DOI: https://doi.org/10.1371/journal.pone.0235148
MANZANET, J. M. P. et al. Feasibility study of a clinical decision support system for polymedicated patients in primary care. Healthcare Technology Letters, v. 10, n. 3, p. 62-72, 2023. DOI: https://doi.org/10.1049/htl2.12046
MARASINE, N. R.; SANKHI, S. Factors associated with antidepressant medication non-adherence. Turkish Journal of Pharmaceutical Sciences, v. 18, n. 2, p. 242-249, 2021. DOI: https://doi.org/10.4274/tjps.galenos.2020.49799
MASNOON, N. et al. What is polypharmacy? A systematic review of definitions. BMC Geriatrics, v. 17, n. 1, p. 1-10, 2017. DOI: https://doi.org/10.1186/s12877-017-0621-2
MOTA, B. A. M.; LANZA, F. M.; NOGUEIRA, D. C. Effectiveness of nursing appointments in adherence to hypertension treatment. Revista de Salud Publica, v. 21, n. 3, p. 324-332, 2019. DOI: https://doi.org/10.15446/rsap.v21n3.70291
MUTH, C. et al. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial. BMJ Open, v. 8, n. 2, p. 1-16, 2018. DOI: https://doi.org/10.1136/bmjopen-2017-017740
PINTO, I. et al. Machine learning tools in chronic disease management: scoping review. Revista de Investigação & Inovação em Saúde, v. 7, n. 1, p. 1-11, 2023. DOI: https://doi.org/10.37914/riis.v7i1.359
PONA, A.; CLINE, A.; FELDMAN, S. R. Reasons for nonadherence. In: FELDMAN, S. R. et al. (ed.). Treatment Adherence in Dermatology. Cham: Springer Nature Switzerland, 2020. p. 1-11. DOI: https://doi.org/10.1007/978-3-030-27809-0
PRADOS-TORRES, A. et al. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implementation Science, v. 12, n. 1, p. 1-10, 2017. DOI: https://doi.org/10.1186/s13012-017-0584-x
SANTOS, B. D. et al. Clinical impact of a comprehensive medication management service in primary health care. Journal of Pharmacy Practice, v. 34, n. 2, p. 265-271, 2021. DOI: https://doi.org/10.1177/0897190019866309
SILVA, I. R. et al. Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil. Revista Brasileira de Epidemiologia, v. 23, p. 1-15, 2020. DOI: https://doi.org/10.1590/1980-549720200077
TRICCO, A. C. et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, v. 169, n. 7, p. 467-473, 2018. DOI: https://doi.org/10.7326/M18-0850
WORLD HEALTH ORGANIZATION. Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf. Acesso em: 26 jan. 2026.
